| Hint | Answer | % Correct |
|---|---|---|
| Analgesic, binds CNS opiate receptors to decrease pain. | Morphine | 87%
|
| Blocks effects of opioids, especially in overdose | Naloxone | 61%
|
| SSRI antidepressant, begins with F... | Fluoxetine | 57%
|
| Nicotinic cholinergic receptor agonist | Nicotine | 57%
|
| Opioid pain medication, begins with T... | Tramadol | 48%
|
| Converted by Cyp450 to morphine, used in pain relief | Codeine | 39%
|
| Atypical antipsychotic, partial 5-HT1A agonist as well as D2 antagonist | Clozapine | 26%
|
| Antipsychotic with high affinity D2 antagonism, begins with H... | Haloperidol | 26%
|
| Dopamine precursor, can cross blood-brain-barrier. Used in Parkinson's treatment. | L-DOPA | 26%
|
| Used in anaesthesia to decrease consciousness, potentiates GABAA receptor activity. | Propofol | 26%
|
| Tricyclic antidepressant - 5HT/NA reuptake inhibitor | Amitriptyline | 22%
|
| Positive modulator of GABAA receptors, used in treatment of anxiety, insomnia | Diazepam | 22%
|
| Local anaesthetic, blocks Na channels | Lidocaine | 22%
|
| Insomnia treatment, increases effect of GABA at GABAA receptor | Temazepam | 22%
|
| Anxiolytic psychotropic, 5-HT1A partial agonist. | Buspirone | 17%
|
| Treatment of major depressive disorder, begins with L... | Lithium | 17%
|
| Antiemitic - highly specific 5-HT3R antagonist | Ondansetron | 17%
|
| Antidepressant - 5-HT/ NA reuptake inhibitor, begins with V... | Venlafaxine | 17%
|
| MAO inhibitor used as antidepressant, anxiolytic | Phenelzine | 13%
|
| Anti-seizure medication, voltage dependent block of VGNa channels, begins with Ph.. | Phenytoin | 13%
|
| Antipsychotic, primarily blocking D2 receptors | Chlorpromazine | 9%
|
| Prevents accommodation of eye, muscarinic antagonist | Cyclopentolate | 9%
|
| General anaesthetic, binds GABA, glutamate, glycine receptors - exact mechanism not clearly delineated. | Isoflurane | 9%
|
| Induces, maintains general anaesthesia. Positive modulator of GABAA receptor | Sevoflurane | 9%
|
| 5-HT receptor agonist used in treatment of migraine | Sumatriptan | 9%
|
| Used to treat epilepsy, bipolar disorder. Increased levels of GABA, blocked of VGNa channels | Valproate | 9%
|
| Non-depolarising block at NMJ | Vecuronium | 9%
|
| Used for peripheral nerve block/ epidural block - binds intracellular portion of VGNa channels, preventing depolarisation. | Bupivacaine | 4%
|
| Use-dependent VGNa channel blocker, used in treatment of epilepsy and neuropathic pain. | Carbamazepine | 4%
|
| Inverse alpha1 agonist used as anxiolytic | Prazosin | 4%
|